Integra LifeSciences Holding Corporation
) has expanded its skin and wound product line with the launch of
Integra Wound Matrix (Thin). However, the announcement failed to
boost Integra's shares as they fell 2.5% till the last trading
Wound Matrix is a new and thinner product with a thickness that
is about half of the previous Integra Wound Matrix. It can be
applied to complex anatomical sites that need a more conformable
The product has received 510(k) clearance from the U.S. Food and
Drug Administration (FDA). The company expects to fully launch
this product in the U.S. next month. It has been featured at the
American Burn Association Annual Meeting from Mar 25 to 28, 2014
in Boston, Mass.
This new product is a collagen-glycosaminoglycan wound matrix,
which supports a healing environment for wound management. It is
available in a variety of sizes and can be used to treat
second-degree burns, partial and full-thickness wounds, pressure
ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers,
tunneled/undermined wounds, surgical wounds (donor site/grafts,
post Moh's surgery, post-laser surgery, podiatric, wound
dehiscence), trauma wounds (abrasions, lacerations, skin tears)
and draining wounds. The terminally sterilized Integra Wound
Matrix (Thin) has a 24-month shelf life when stored at room
temperature but for single use only
Integra LifeSciences, a leading surgical implants and medical
instruments maker, offers a versatile range of skin repair
solutions to meet the surgeon's procedural needs. Its skin
products include Integra Dermal Regeneration Template, one of the
first regenerative products approved by the FDA, Integra Meshed
Milayer Wound Matrix, which can be used with Negative Pressure
Wound Therapy, and Integra Flowable Wound Matrix, designed for
easy treatment of tunneled and undermined wounds.
Integra LifeSciences, which currently carries a Zacks Rank #3
(Hold), offers orthopedic extremity surgery, neurosurgery,
reconstructive, spine and general surgery. The company's Ultra
Pure Collagen is the base material of implants and has been
successfully used in more than 12 million procedures.
Some better-ranked stocks worth considering in the broader
medical sector include
ANI Pharmaceuticals, Inc
Alexion Pharmaceuticals, Inc.
), all of which hold a Zacks rank #1 (Strong Buy).
ALKERMES INC (ALKS): Free Stock Analysis
ALEXION PHARMA (ALXN): Free Stock Analysis
ANI PHARMACEUT (ANIP): Free Stock Analysis
INTEGRA LIFESCI (IART): Free Stock Analysis
To read this article on Zacks.com click here.